Kraig Biocraft Laboratories Fulfilling Order for Customized Spider Silk Application from Leading Performance Sports Brand
Kraig Biocraft Laboratories (OTCQB: KBLB) is fulfilling an order of its next-generation recombinant spider silk yarns for a confidential pilot program with a globally recognized performance sports apparel brand.
The company is converting part of its spider silk inventory into yarns tailored to the customer's specifications; delivery is expected before the end of the first quarter of 2026. The pilot uses a small, purpose-built quantity intended to demonstrate commercial and performance potential while details remain confidential.
Kraig Biocraft Laboratories (OTCQB: KBLB) sta evadendo un ordine dei suoi filati di seta di ragno ricombinante di nuova generazione per un programma pilota riservato con un marchio globale riconosciuto nel settore dell'abbigliamento sportivo ad alte prestazioni.
L'azienda sta convertendo parte dell'inventario di seta di ragno in filati su misura per le specifiche del cliente; la consegna è prevista entro la fine del primo trimestre del 2026. Il pilota utilizza una piccola quantità appositamente realizzata per dimostrare potenziale commerciale e prestazionale, mentre i dettagli restano riservati.
Kraig Biocraft Laboratories (OTCQB: KBLB) está atendiendo un pedido de sus hilos de seda de araña recombinante de próxima generación para un programa piloto confidencial con una reconocida marca global de prendas deportivas técnicas.
La empresa está convirtiendo parte de su inventario de seda de araña en hilos hechos a medida según las especificaciones del cliente; se espera la entrega antes de finalizar el primer trimestre de 2026. El piloto utiliza una cantidad pequeña y creada a propósito para demostrar el potencial comercial y de rendimiento, mientras los detalles permanecen confidenciales.
Kraig Biocraft Laboratories (OTCQB: KBLB)는 세계적으로 인정받는 스포츠 퍼포먼스 의류 브랜드와의 기밀 파일럿 프로그램을 위해 차세대 재조합 거미 실크 원사를 주문대로 이행하고 있습니다.
회사는 고객의 사양에 맞춰 거미 실크 재고의 일부를 원사로 전환하고 있습니다; 납기는 2026년 1분기 말 이전으로 예상됩니다. 파일럿은 상업적 및 성능 잠재력을 입증하기 위해 의도적으로 소량으로 구성된 것이며, 세부 정보는 비밀로 남아 있습니다.
Kraig Biocraft Laboratories (OTCQB: KBLB) satisfait une commande de fils de soie d'araignée recombinante de nouvelle génération pour le compte d'un programme pilote confidentiel avec une marque mondiale reconnue dans le domaine des vêtements de sport performants.
L'entreprise convertit une partie de son stock de soie d'araignée en fils adaptés aux spécifications du client; la livraison est attendue avant la fin du premier trimestre 2026. Le pilote utilise une petite quantité spécialement conçue pour démontrer le potentiel commercial et de performance, tandis que les détails restent confidenciels.
Kraig Biocraft Laboratories (OTCQB: KBLB) erfüllt eine Bestellung seiner Seide aus Spinnen-Rekombinanten der nächsten Generation für ein vertrauliches Pilotprogramm mit einer weltweit anerkannten Marke im Bereich Performance-Sportbekleidung.
Das Unternehmen wandelt einen Teil seines Spinnen-Seideninventars in Garn um, das nach den Kundenspezifikationen zugeschnitten ist; die Lieferung wird voraussichtlich bis Ende des ersten Quartals 2026 erfolgen. Der Pilot nutzt eine kleine, speziell dafür zusammengestellte Menge, um das kommerzielle und leistungsbezogene Potenzial zu demonstrieren, während Details vertraulich bleiben.
Kraig Biocraft Laboratories (OTCQB: KBLB) يفي بطلب لغايات خيوط حرير العنكبوت الهندسية من الجيل التالي لبرنامج تجريبي سري مع علامة تجارية عالمية معروفة في مجال أزياء الأداء الرياضي.
الشركة تقوم بتحويل جزء من مخزونها من حرير العنكبوت إلى خيوط مصممة وفق مواصفات العميل؛ من المتوقع التسليم قبل نهاية الربع الأول من عام 2026. التجريبي يستخدم كمية صغيرة مصممة لغرض الاختبار لإثبات الإمكانات التجارية والأداء بينما تبقى التفاصيل سرية.
- None.
- None.
Company to deliver spider silk yarns for elite-tier athletic application
ANN ARBOR, Mich., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it is fulfilling an order for spider silk from a globally recognized performance sports apparel brand as part of a confidential pilot development program.
This project will incorporate the Company’s next-generation recombinant spider silk into a cutting-edge application targeted at the highest tier of performance apparel. While specific project details remain protected, Kraig Labs can confirm that the program is designed for one of the most demanding and innovation-focused segments of the athletic market.
This customer's market leadership, engineering sophistication, and reputation for excellence in performance apparel made them the ideal choice for this initial pilot engagement. Their market leadership and commitment to innovation is the reason Kraig Labs selected to fulfill this request from among the numerous recent inbound inquiries it received.
The Company is now processing a portion of its recombinant spider silk inventory into yarns tailored to the precise specifications provided by the customer's development team. Delivery of these specialized materials is expected before the end of the first quarter.
As a focused pilot program, this order calls for a small, purpose-built quantity of spider silk designed explicitly for this highly specialized application. Even at this limited scale, the project provides a powerful platform for demonstrating the performance capabilities and commercial potential of the Company's specialized spider silk technology within a premier performance environment.
"This collaboration underscores the growing recognition of our material's potential in high-value, high-performance applications," said Kim Thompson, Kraig Labs’ Founder and CEO. "We are excited to support this project and a customer whose commitment to innovation aligns with our own. We look forward to showcasing what our spider silk can deliver at the elite level of apparel design and performance."
Kraig Labs will share additional updates as appropriate and consistent with the confidentiality terms of the agreement.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about other recent Kraig Labs advancements, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, Inc.
(720) 288-8495